Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

This Drug Combination for Eli Lilly Generated Significantly More Weight Loss Than Just Zepbound, but Discontinuation Rates Were Also Far Higher. Here's What This Could Mean for the Stock

Eli Lilly isn't content with the success of its current GLP-1 drugs; it's on the hunt for even better weight loss solutions.

We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.

Also reported by 1 other outlet

Read the original at fool.com →

More in Finance & Markets

PSX Suffers Massive Crash Again

Pakistan Stock Exchange (PSX) fell sharply on Monday as political uncertainty surrounding the federal government’s emergency decision in Khyber Pakhtunkhwa … Read More The post PSX Suffers Massive…

More from Monday 12 October →